Xiaoqiang Xiang
Guangzhou University of Chinese Medicine
ORCID: 0000-0002-8683-2603Also affiliated with Guangdong Pharmaceutical University, American Association of Colleges of Pharmacy, Fudan University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Ministry of Education, Quzhou University, Pharmaceutical Formulations (United States), Obstetrics and Gynecology Hospital of Fudan University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 1 paper. Top paper: “Examination of the Impact of CYP3A4/5 on Drug–Drug Interaction between Schizandrol A/Schizandrol B and Tacrolimus (FK-506): A Physiologically Based Pharmacokinetic Modeling Approach”.
Fengjiao Bu, Qizhen Wang, Min Li, Jiaying Lin, Zhijia Tang +6 more